Questions answered · 06
Thymulin: Questions Answered from the Research Record
Direct answers, cited where they make a quantitative claim, and honest where the literature is thin.
What is thymulin?
Thymulin (zinc-bound serum thymic factor; FTS-Zn) is a zinc-dependent nonapeptide hormone produced exclusively by thymic epithelial cells [4]. It is biologically active only when bound to zinc in a 1:1 ratio [1]. It is a research peptide, not FDA-approved, and is distinct from thymosin alpha-1 and thymosin beta-4 [4].
What is thymulin peptide?
Thymulin is a linear nonapeptide with the sequence pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn [1]. It is handled in the laboratory as a research peptide. Its defining feature is strict zinc dependence: the zinc-free apopeptide is inactive until one zinc ion binds per molecule [1].
What does thymulin do in the body?
Endogenously, thymulin drives T-lymphocyte differentiation and modulates immune-cell function, and it acts as a hypophysiotropic peptide in a bidirectional thymus-neuroendocrine axis — for example, stimulating pituitary ACTH release in vitro [4][12]. It circulates from birth, peaks in childhood, and declines with age and zinc deficiency [4].
What are the benefits of thymulin peptide?
In preclinical research, thymulin has been studied for T-cell differentiation and for anti-inflammatory activity. In LPS-treated mice it lowered plasma pro-inflammatory cytokines and inducible heat-shock proteins and modulated NF-kB/JNK signaling [6]. These are research findings in animal and in-vitro models, not established human benefits.
What are the benefits of thymulin?
Reported research effects span immune, anti-inflammatory, and neuroendocrine domains. As a zinc-dependent thymic hormone, thymulin drives T-lymphocyte differentiation in vitro [12] and restrains cytokine overproduction in inflammation models [9]; it also acts on the pituitary within the thymus-neuroendocrine axis [4]. All findings are from study species and models.
Does thymulin reduce inflammation?
In multiple rodent models, thymulin was associated with reduced inflammation: in LPS-treated mice it prevented overproduction of pro-inflammatory cytokines and Hsp70 [9], and intracerebroventricular thymulin reduced hippocampal NF-kB activation [10]. These are preclinical observations, not a demonstrated anti-inflammatory treatment in people.
Does thymulin boost the immune system?
In research models thymulin promotes T-cell maturation: synthetic thymulin induced T-cell markers on human marrow precursors in vitro, and its activity tracks zinc status [12]. In human zinc deficiency, serum thymulin activity fell and recovered with zinc repletion [3]. These are preclinical and in-vitro findings; thymulin is not an approved immune therapy.
Can thymulin help with autoimmune disease?
In a mouse model of severe experimental autoimmune encephalomyelitis (EAE, a multiple-sclerosis model), thymulin modulated the inflammatory response and reduced disease severity [4]. This is an animal-model finding, not evidence that thymulin treats autoimmune disease in people.
What research exists on thymulin?
Thymulin research spans its zinc-dependent identity and T-cell differentiation [1][12], anti-inflammatory and NF-kB-related mechanisms [6][10], neuroinflammation and analgesia [4], the thymus-neuroendocrine axis [4], and gene-therapy delivery in animal models [5][7]. Most evidence is preclinical — cell and animal — with limited and dated human data [3][13].
Does thymulin have anti-aging effects?
Circulating thymulin declines with age, partly because of reduced zinc saturation of the peptide; in aged mice, zinc repletion restored thymic function and thymulin activity [14]. This is a zinc-and-immunosenescence research finding, not a demonstrated anti-aging effect in humans.
Is thymulin studied for pain relief?
Yes, in animal models: intraperitoneal and intracerebroventricular thymulin reduced inflammatory hyperalgesia in rodents, and a thymulin-related analog showed analgesic activity [4]. Thymulin alone did not change baseline pain. These are preclinical analgesia findings only.
Why does thymulin need zinc to work?
Zinc binding gives thymulin a specific three-dimensional conformation required for activity. Chelating the zinc (for example with Chelex) abolishes biological activity in bioassays, and adding zinc back restores it, with an optimal 1:1 metal-to-peptide ratio [1].
What is the amino acid sequence of thymulin?
Thymulin is a nonapeptide with the sequence pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (<Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn), molecular formula C33H54N12O15 [1]. Zinc binds this peptide in a 1:1 ratio to produce the active conformation [1].
Is thymulin the same as serum thymic factor (FTS)?
Serum thymic factor (FTS, "facteur thymique serique") is the original name for the peptide. Researchers proposed the name "thymulin" specifically for the zinc-bound, biologically active form (FTS-Zn); the zinc-free form is the inactive apopeptide [1].
How is thymulin different from thymosin alpha-1?
Thymulin is a zinc-dependent nonapeptide active only when zinc-bound; thymosin alpha-1 is a different, longer thymic peptide [1][4]. They are chemically and pharmacologically distinct, and thymulin's research data should never be described using thymosin alpha-1's name or findings.
What doses of thymulin were used in animal studies?
Reported research doses are small and route-specific: for example 0.1-1 microgram intracerebroventricular and 1-1000 nanograms intraperitoneal in rodent neuroinflammation and analgesia models [10]. These are study doses in named species, reported only as findings, never as guidance for humans.
What is the dosage of thymulin peptide?
There is no established human dose. Published research reports study doses by species and route only — for example nanogram-to-low-microgram amounts in rodents [10][11]. Native thymulin's human pharmacokinetics and standardized dosing are not well characterized in the public literature [4].
How is thymulin administered in research?
Routes used in studies include intraperitoneal, subcutaneous, intracerebroventricular, intratracheal (for gene therapy), topical (a zinc-thymulin pilot), and in vitro [7][11]. Gene-therapy approaches deliver a vector rather than the peptide itself to sustain circulating thymulin [5].
Is thymulin taken as an injection?
In animal research, thymulin has most often been given by injection — intraperitoneal or subcutaneous — or directly into the brain (intracerebroventricular) [10][11]. It is a research peptide, not an approved injectable medicine, so this describes laboratory administration in study species, not a human regimen.
Is there a thymulin supplement?
No. Thymulin is not a dietary supplement; it is handled as a research peptide for laboratory use [4]. Because its activity depends on zinc, much of the human-relevant literature concerns zinc status and its effect on endogenous thymulin rather than supplementing the peptide [3].
What is the half-life of thymulin?
As a small peptide, native thymulin has a short circulating half-life, but its precise human pharmacokinetic half-life is not well established in the public literature [4]. Gene-therapy approaches were developed specifically to sustain circulating thymulin levels over time [5].
What are the side effects of thymulin peptide?
Human safety data are limited and dated. Early controlled and open human trials used a synthetic analog and FTS-Zn in rheumatoid arthritis, and a small pilot studied topical zinc-thymulin; there are no large modern human safety trials of native thymulin [4]. A thorough side-effect profile in humans is not established.